Lincoln Institute Of Reproductive Medicine Private Limited
Founded in 2021 and headquartered in Chandigarh, India.
2021 | Chandigarh (India) | Active
Lincoln Institute Of Reproductive Medicine Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2022
About Lincoln Institute Of Reproductive Medicine
Lincoln Institute Of Reproductive Medicine Private Limited (LIORMPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 March 2021 (Three years and 11 months 5 days old ). Its registered office is in Chandigarh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Narinder Pahuja and Avtar Pahuja serve as directors at the Company.
Company Details
- Location
Chandigarh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85100CH2021PTC043587
- Company No.
043587
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Mar 2021
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Healthcare
Who are the key members and board of directors at Lincoln Institute Of Reproductive Medicine?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narinder Pahuja  | Director | 24-Mar-2021 | Current |
| Avtar Pahuja | Director | 24-Mar-2021 | Current |
Financial Performance of Lincoln Institute Of Reproductive Medicine.
Lincoln Institute Of Reproductive Medicine Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Lincoln Institute Of Reproductive Medicine?
Unlock access to Lincoln Institute Of Reproductive Medicine's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Lincoln Institute Of Reproductive Medicine?
Unlock and access historical data on people associated with Lincoln Institute Of Reproductive Medicine, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lincoln Institute Of Reproductive Medicine, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lincoln Institute Of Reproductive Medicine's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.